{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:21:06Z","timestamp":1790778066331,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R44AI106235"],"award-info":[{"award-number":["R44AI106235"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.bmcl.2017.04.004","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T13:47:00Z","timestamp":1491227220000},"page":"2465-2471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["A calcineurin antifungal strategy with analogs of FK506"],"prefix":"10.1016","volume":"27","author":[{"given":"Mitchell","family":"Nambu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Covel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mili","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly K.","family":"Moloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi M.","family":"Numa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinlyn A.","family":"Soltow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trzoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Robert R.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Mutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2017.04.004_b0005","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1086\/323900","article-title":"The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis, Mycoses Study Group","volume":"33","author":"Perfect","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmcl.2017.04.004_h0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/AAC.41.1.156","article-title":"The immunosuppressant FK506 and its nonimmunosuppressive analog L-685, 818 are toxic to Cryptococcus neoformans by inhibition of a common Target protein","volume":"41","author":"Odom","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2017.04.004_h0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/AAC.44.1.143-149.2000","article-title":"Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin","author":"Cruz","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2017.04.004_h0020","first-page":"418","article-title":"Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections","volume":"5","author":"Steinbach","year":"2007","journal-title":"Nat Rev"},{"key":"10.1016\/j.bmcl.2017.04.004_h0025","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/emboj\/16.10.2576","article-title":"Calcineurin is required for virulence of Cryptococcus neoformans","volume":"16","author":"Odom","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.bmcl.2017.04.004_h0030","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1128\/EC.00139-06","article-title":"Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus","volume":"5","author":"Steinbach","year":"2006","journal-title":"Eukaryot Cell"},{"issue":"12","key":"10.1016\/j.bmcl.2017.04.004_h0035","doi-asserted-by":"crossref","first-page":"e51403","DOI":"10.1371\/journal.pone.0051403","article-title":"The Crz1\/Sp1 transcription factor of cryptococcus neoformans is activated by calcineurin and regulates cell wall integrity","volume":"7","author":"Lev","year":"2012","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.bmcl.2017.04.004_b0015","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/00007890-199457120-00001","article-title":"The antimicrobial activities of cyclosporine, FK506, and rapamycin","volume":"57","author":"High","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.bmcl.2017.04.004_b0020","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","article-title":"Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes","volume":"66","author":"Liu","year":"1991","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bmcl.2017.04.004_b0025","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1084\/jem.20092531","article-title":"Calcineurin regulates innate antifungal immunity in neutrophils","volume":"207","author":"Greenblatt","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.bmcl.2017.04.004_b0030","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0952-7915(92)90024-9","article-title":"Immunosuppressive mechanism of action and beyond","volume":"5","author":"Siekierka","year":"1992","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.bmcl.2017.04.004_b0035","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/365352a0","article-title":"The T-cell transcription factor NF-ATp is a substrate for calcineurin and interacts with Fos and Jun","volume":"365","author":"Jain","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2017.04.004_h0065","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/352803a0","article-title":"Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A","volume":"352","author":"Flanagan","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2017.04.004_h0070","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/S0021-9258(18)53861-8","article-title":"Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T-cells (NF-AT) complex","volume":"268","author":"Northrop","year":"1993","journal-title":"Biol Chem"},{"key":"10.1016\/j.bmcl.2017.04.004_b0045","first-page":"651","volume":"13","author":"Organ","year":"1993","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2017.04.004_b0050","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.176.3.751","article-title":"The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin","volume":"176","author":"Dumont","year":"1992","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.bmcl.2017.04.004_b0055","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00007890-199603270-00015","volume":"61","author":"Koprak","year":"1996","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.bmcl.2017.04.004_b0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2133\/dmpk.DMPK-13-RG-060","article-title":"Association between CYP3A5 genotypes in graft liver and increase in tacromilus biotransformation from steroid treatment in living-donor liver transplant patients","volume":"29","author":"Hosohata","year":"2014","journal-title":"Drug Metab Pharamacokinet"},{"key":"10.1016\/j.bmcl.2017.04.004_b0065","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1016\/j.bmc.2009.07.030","article-title":"Synthesis of orthogonally reactive FK506 derivatives via olefin cross metathesis","volume":"17","author":"Marinec","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2017.04.004_b0070","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1021\/ja00063a082","article-title":"1-Hydroxy-7-azabenzotriazole, an efficient peptide coupling additive","volume":"115","author":"Carpino","year":"1993","journal-title":"JACS"},{"issue":"22","key":"10.1016\/j.bmcl.2017.04.004_b0075","doi-asserted-by":"crossref","first-page":"11400","DOI":"10.1039\/c3ra47867j","article-title":"Facile functionalization of FK506 for biological studies by the thiol-ene 'click' reaction","volume":"4","author":"Guo","year":"2014","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmcl.2017.04.004_b0080","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1021\/jo960057x","article-title":"Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride, studies on direct and indirect reductive amination procedures","volume":"61","author":"Abdel-Magid","year":"1996","journal-title":"JOC"},{"issue":"20","key":"10.1016\/j.bmcl.2017.04.004_b0085","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1021\/jm031101l","volume":"47","author":"Hersperger","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.04.004_b0090","unstructured":"Schlachter ST, Gaudino JJ, Burgess LE, Hunt KW, Macrocyclic Analogs for the Treatment of Immunoregulatory Disorders and Respiratory Diseases, US0160838, 2006."},{"issue":"18","key":"10.1016\/j.bmcl.2017.04.004_b0095","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/0960-894X(96)00398-8","volume":"6","author":"Sinclair","year":"1996","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2017.04.004_b0100","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/cbic.200800806","article-title":"Fluorescent probes to characterize FK506-binding proteins","volume":"10","author":"Kozany","year":"2009","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bmcl.2017.04.004_b0105","unstructured":"R & D systems, Inhibition of Calcineurin Phosphatase Activity, https:\/\/www.rndsystems.com\/resources\/protocols\/inhibition-calcineurin-phosphatase-activity, (accessed 04\/01\/2016), FK506 was added for competition."},{"key":"10.1016\/j.bmcl.2017.04.004_b0110","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4049\/jimmunol.134.2.663","volume":"134","author":"Imboden","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.bmcl.2017.04.004_h0145","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jim.2014.05.019","article-title":"Leukopak PBMC sample processing for preparing quality control material to support proficiency testing programs","volume":"409","author":"Ambrosia","year":"2014","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.bmcl.2017.04.004_h0150","doi-asserted-by":"crossref","unstructured":"Kruisbeek A.M., Shevach E, Thornton AM, Proliferative Assays for T Cell Function, Current Protocols in Immunology, Supplement 60, Current Protocols in Immunolog, John Wiley & Sons Inc, 2004, 3.12.1-3.12.20.","DOI":"10.1002\/0471142735.im0312s60"},{"key":"10.1016\/j.bmcl.2017.04.004_h0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cryobiol.2008.06.002","article-title":"T cell responses in fresh and cryopreserved peripheral blood mononuclear cells: Kinetics of cell viability, cellular subsets, proliferation, and cytokine production","volume":"57","author":"Jeurink","year":"2008","journal-title":"Cryobiology"},{"issue":"1\u20133","key":"10.1016\/j.bmcl.2017.04.004_b0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmcl.2017.04.004_b0125","unstructured":"Rex JH, Alexander BD, Andes D, et al. Espinel-Ingrofff, Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved Standard-Second edition. 2008, CLSI document, vol 28, no. 16, M38-A2."},{"issue":"1","key":"10.1016\/j.bmcl.2017.04.004_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2004.06.016","article-title":"Neuroimmunophilins: a novel drug treatment for the reversal of neurodegenerative disease","volume":"128","author":"Poulter","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.bmcl.2017.04.004_b0140","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1128\/iai.18.3.775-779.1977","article-title":"Vero response to a cytotoxin of Escherichia coli","volume":"18","author":"Konowalchuk","year":"1977","journal-title":"Infect Immun"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17303670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17303670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:20:51Z","timestamp":1760772051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X17303670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0960894X17303670"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.04.004","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A calcineurin antifungal strategy with analogs of FK506","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}